Digital Health Start-Ups Continue To Be Attractive SPAC Targets
According to Rock Health, 52 health-care focused SPACs are looking for targets. This comes as blank check companies are facing rising scrutiny by regulators.
You may also be interested in...
Since going public, the company’s share price has flopped, its board has seen a flurry of appointments and resignations over the past year, and now the company is facing investor lawsuits.
With the acquisition of Lemonaid Health, at-home genome testing company 23andMe hopes to transform the primary care business with genetics insights.
Investors have been wary of LuminaraDX since its placement on NASDAQ, driving the share price down.